1391575-90-8Relevant articles and documents
QUINOXALINE DERIVATIVES
-
, (2021/07/24)
The present invention relates to compounds according to general formula (I), which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.
Continuous-flow synthesis of monoarylated acetaldehydes using aryldiazonium salts
Chernyak, Natalia,Buchwald, Stephen L.
supporting information; experimental part, p. 12466 - 12469 (2012/09/05)
Anilines and ethyl vinyl ether can be used as precursors for a process that is the synthetic equivalent of the α-arylation of acetaldehyde enolate. The reaction manifests a high level of functional group compatibility, allowing the ready preparation of a number of synthetically valuable compounds.